{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:06:16Z","timestamp":1792145176317,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jbo.2020.100281","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T17:27:13Z","timestamp":1581528433000},"page":"100281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice"],"prefix":"10.1016","volume":"21","author":[{"given":"Sun","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2020.100281_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/959248","article-title":"The molecular pathogenesis of osteosarcoma: a review","volume":"2011","author":"Broadhead","year":"2011","journal-title":"Sarcoma"},{"key":"10.1016\/j.jbo.2020.100281_bib0002","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/548151","article-title":"Using epidemiology and genomics to understand osteosarcoma etiology","volume":"2011","author":"Savage","year":"2011","journal-title":"Sarcoma"},{"key":"10.1016\/j.jbo.2020.100281_bib0004","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbo.2020.100281_bib0005","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/pbc.25459","article-title":"Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults","volume":"62","author":"Eleut\u00e9rio","year":"2015","journal-title":"Pediatr. Blood. Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0006","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00432-007-0330-x","article-title":"A review of clinical and molecular prognostic factors in osteosarcoma","volume":"134","author":"Clark","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0007","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0008","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","article-title":"Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"21","author":"Kager","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0009","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00432-009-0690-5","article-title":"Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients","volume":"136","author":"Harting","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0010","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1023\/A:1011636912674","article-title":"Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli institute","volume":"12","author":"Ferrari","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0011","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1200\/JCO.2012.43.8598","article-title":"Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis","volume":"31","author":"Collins","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0012","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.canep.2015.10.016","article-title":"Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: a series from Chiang Mai University hospital","volume":"39","author":"Pruksakorn","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.jbo.2020.100281_bib0013","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.canep.2015.05.001","article-title":"Prognostic factors for survival in patients with high-grade osteosarcoma using the surveillance, epidemiology, and end results (SEER) program database","volume":"39","author":"Duchman","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.jbo.2020.100281_bib0014","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ejso.2016.04.056","article-title":"Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: a meta-analysis","volume":"42","author":"Li","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0015","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/j.jbo.2020.100281_bib0016","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jbo.2020.100281_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnci.2014.11.001","article-title":"Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: implication in tumor progression and prognosis","volume":"27","author":"Abd El-Rehim","year":"2015","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"10.1016\/j.jbo.2020.100281_bib0018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/0284186X.2014.925139","article-title":"The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database","volume":"54","author":"Aggerholm-Pedersen","year":"2015","journal-title":"Acta Oncol. (Madr.)"},{"key":"10.1016\/j.jbo.2020.100281_bib0019","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.spinee.2016.11.002","article-title":"Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine","volume":"17","author":"Arshi","year":"2017","journal-title":"Spine J."},{"key":"10.1016\/j.jbo.2020.100281_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/516843","article-title":"Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the \"classical\" patient","volume":"2015","author":"Berner","year":"2015","journal-title":"Sarcoma"},{"key":"10.1016\/j.jbo.2020.100281_bib0021","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.21873\/anticanres.13365","article-title":"Prognostic impact of proximal versus distal localization in extremity long bone osteosarcomas","volume":"39","author":"Berner","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jbo.2020.100281_bib0022","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ejso.2016.01.016","article-title":"Pathologic fracture a poor prognostic factor in osteosarcoma: misleading conclusions from meta-analyses?","volume":"42","author":"Cates","year":"2016","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"10.1016\/j.jbo.2020.100281_bib0023","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3109\/0284186X.2016.1156740","article-title":"Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: a retrospective cohort study of 153 patients","volume":"55","author":"Cates","year":"2016","journal-title":"Acta Oncol. (Madr.)"},{"key":"10.1016\/j.jbo.2020.100281_bib0024","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/PAS.0000000000000995","article-title":"Modeling continuous prognostic factors in survival analysis: implications for tumor staging and assessing chemotherapy effect in osteosarcoma","volume":"42","author":"Cates","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jbo.2020.100281_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8631237","article-title":"Periosteal osteosarcoma: a single-institutional study of factors related to oncologic outcomes","volume":"2018","author":"Chan","year":"2018","journal-title":"Sarcoma"},{"key":"10.1016\/j.jbo.2020.100281_bib0026","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1111\/ajco.12346","article-title":"Prognostic factors and survival rate of osteosarcoma: a single-institution study","volume":"13","author":"Faisham","year":"2017","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0027","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12891-018-2217-1","article-title":"Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan","volume":"19","author":"Fukushima","year":"2018","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.jbo.2020.100281_bib0028","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12094-009-0388-9","article-title":"Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma","volume":"11","author":"Gonz\u00e1lez-Billalabeitia","year":"2009","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0029","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bone.2011.08.014","article-title":"Age as prognostic factor in patients with osteosarcoma","volume":"49","author":"Hagleitner","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2020.100281_bib0030","doi-asserted-by":"crossref","first-page":"43130","DOI":"10.18632\/oncotarget.17811","article-title":"Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbo.2020.100281_bib0031","doi-asserted-by":"crossref","first-page":"e3420","DOI":"10.1097\/MD.0000000000003420","article-title":"Improvement in high-grade osteosarcoma survival: results from 202 patients treated at a single institution in Taiwan","volume":"95","author":"Hung","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbo.2020.100281_bib0032","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1245\/s10434-013-3210-4","article-title":"Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases","volume":"21","author":"Iwata","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0033","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1002\/cncr.27414","article-title":"Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group","volume":"118","author":"Janeway","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0034","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaoto.2015.0340","article-title":"Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study prognostic factors of osteosarcoma of the jaws prognostic factors of osteosarcoma of the jaws","volume":"141","author":"Lee","year":"2015","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jbo.2020.100281_bib0035","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.2147\/OTT.S140560","article-title":"Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma","volume":"10","author":"Li","year":"2017","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.jbo.2020.100281_bib0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12957-018-1344-3","article-title":"The extremity localized classic osteosarcomas have better survival than the axial non-classics","volume":"16","author":"Lin","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0037","doi-asserted-by":"crossref","first-page":"39862","DOI":"10.1038\/srep39862","article-title":"Prognostic value of inflammation-based scores in patients with osteosarcoma","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbo.2020.100281_bib0038","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.fob.2015.08.002","article-title":"Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma","volume":"5","author":"Liu","year":"2015","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.jbo.2020.100281_bib0039","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pbc.25307","article-title":"Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma","volume":"62","author":"Loh","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00701-018-3754-y","article-title":"Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis","volume":"161","author":"Martin","year":"2019","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.jbo.2020.100281_bib0041","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejca.2011.09.012","article-title":"Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup","volume":"48","author":"McTiernan","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0042","doi-asserted-by":"crossref","first-page":"e71362","DOI":"10.1371\/journal.pone.0071362","article-title":"Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft","volume":"8","author":"Miwa","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jbo.2020.100281_bib0043","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jso.24045","article-title":"Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: a single-center experience of 237 patients","volume":"112","author":"Nataraj","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0044","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jso.21287","article-title":"Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese Musculoskeletal Oncology Group","volume":"100","author":"Nishida","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0045","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1002\/cncr.29575","article-title":"Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: a multi-institutional study","volume":"121","author":"Ogura","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0046","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jso.24809","article-title":"A study of 853 high grade osteosarcomas from a single institution\u2014Are outcomes in Indian patients different?","volume":"117","author":"Puri","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0047","doi-asserted-by":"crossref","first-page":"E1088","DOI":"10.21037\/jtd.2017.11.111","article-title":"Primary thoracic extraskeletal osteosarcoma: a case report and literature review","volume":"9","author":"Qian","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.jbo.2020.100281_bib0048","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3892\/mco.2014.426","article-title":"Factors predicting survival following complete surgical remission of pulmonary metastasis in osteosarcoma","volume":"3","author":"Salah","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0049","first-page":"11364","article-title":"Vitronectin significantly influences prognosis in osteosarcoma","volume":"8","author":"Shi","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jbo.2020.100281_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","article-title":"Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort","volume":"109","author":"Smeland","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0051","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/MPH.0000000000000911","article-title":"Pretreatment neutrophil-to-lymphocyte ratio and lymphocyte recovery: independent prognostic factors for survival in pediatric sarcomas","volume":"39","author":"Vasquez","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0052","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fonc.2016.00022","article-title":"Analysis of prognostic factors in high-grade osteosarcoma of the extremities in children: a 15-Year single-institution experience","volume":"6","author":"Vasquez","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0053","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/annonc\/mdr491","article-title":"Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials","volume":"23","author":"Whelan","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0054","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.2147\/CMAR.S177945","article-title":"Nomogram application to predict overall and cancer-specific survival in osteosarcoma","volume":"10","author":"Zheng","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.jbo.2020.100281_bib0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ocl.2015.08.022","article-title":"Update on survival in osteosarcoma","volume":"47","author":"Anderson","year":"2016","journal-title":"Orthop. Clin. N. Am."},{"key":"10.1016\/j.jbo.2020.100281_bib0056","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrendo.2017.16","article-title":"Germline and somatic genetics of osteosarcoma \u2014 connecting aetiology, biology and therapy","volume":"13","author":"Gianferante","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jbo.2020.100281_bib0057","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/BLO.0b013e318059b8c9","article-title":"Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: national cancer data base report","volume":"459","author":"Damron","year":"2007","journal-title":"Clin. Orthop. Relat. Res.\u00ae"},{"key":"10.1016\/j.jbo.2020.100281_bib0058","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3346\/jkms.2006.21.4.715","article-title":"Primary osteosarcoma in patients older than 40 years of age","volume":"21","author":"Jeon","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jbo.2020.100281_bib0059","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1245\/ASO.2004.03.004","article-title":"Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases\u2014an experience in Northern Japan","volume":"11","author":"Okada","year":"2004","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0060","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.ejca.2007.07.004","article-title":"Do pathological fractures influence survival and local recurrence rate in bony sarcomas?","volume":"43","author":"Bramer","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0061","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/cncr.11456","article-title":"Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity","volume":"97","author":"Bacci","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0062","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.1994.12.2.423","article-title":"Prognostic factors in osteosarcoma: a critical review","volume":"12","author":"Davis","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0063","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ejso.2009.01.011","article-title":"Prognostic factors in localized extremity osteosarcoma: a systematic review","volume":"35","author":"Bramer","year":"2009","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0064","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0959-8049(02)00037-0","article-title":"Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? a study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup","volume":"38","author":"Hauben","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbo.2020.100281_bib0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jso.21542","article-title":"Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma","volume":"102","author":"Ferguson","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100281_bib0066","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00003086-200204000-00008","article-title":"Primary osteosarcoma in adults older than 40 years","author":"Carsi","year":"2002","journal-title":"Clin. Orthop. Relat. Res."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137419302362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137419302362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:17:12Z","timestamp":1761941832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137419302362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":66,"alternative-id":["S2212137419302362"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2020.100281","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2020.100281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100281"}}